Traditional Chinese medicine for treating cancer related anemia

Abstract

The invention relates to the field of medicine formulae, and in particular relates to a traditional Chinese medicine for treating cancer related anemia. The traditional Chinese medicine is characterized by being prepared from the following raw material medicines in parts by weight: 25-35 parts of griffith woodsorrel herb, 20-30 parts of rhizoma curculiginis, 15-30 parts of spina date seeds, 10-20 parts of raspberry, 25-35 parts of Indian strawberry, 10-15 parts of orchis, 15-25 parts of himalayan prinsepia leaves, 15-20 parts of radix ranunculi ternate, 20-35 parts of indigo naturalis, 15-25 parts of dendrobe, 15-20 parts of Chinese actinidia root, 20-30 parts of polygonum cuspidatum, 15-25 parts of rhizoma polygonati, 15-25 parts of sida acuta, 15-25 parts of conyza blinii, 20-25 parts of red-knees herb, 15-25 parts of yichang meadow rue, 20-25 parts of longleaf luckyweed flower and 15-25 parts of fingered citron. The above 19 raw material medicines are mixed and soaked and boiled with water, and the residues are removed so as to obtain the filtrate. The traditional Chinese medicine can be used for remarkably relieving the clinical symptoms of patients, increasing the number of red blood cells and the amount of hemoglobin in peripheral blood of patients, and is definite in treatment effect, low in expense and free of conspicuous side effect.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a traditional Chinese medicine for treating tumor-related anemia. Background technique [0002] As we all know, cancer-related anemia (Cancer Related Anemia, CRA), also known as cancerous anemia, is one of the most common accompanying diseases of malignant tumors. In addition to the primary tumor, malignant tumors are prone to complications such as anemia, thrombus, and bone metastasis. The occurrence of tumor-related anemia is caused by a variety of reasons, mainly including two types of factors: tumor-related factors (such as: blood loss, hemolysis, bone marrow invasion) or factors related to tumor treatment (such as: bone marrow damage caused by chemotherapy) Inhibition, tumor radiation therapy, etc.). Anemia is diagnosed when the hemoglobin is less than 11 g / dL or when the hemoglobin is ≥2 g / dL lower than the baseline value. [0003] In traditional Chinese medicine,...

AI Technical Summary

Problems solved by technology

However, EPO treatment is also very controversial. Some studies have questioned whether EPO will shorten the survival time of patients? In any case, the side effects and high costs of the above methods limit its clinical application

Images